Paperonium

COVID-19 · PLoS Pathog · 2021

Summary says COVID-19 patients’ liver-damage marker was lower than healthy people’s. The paper’s own table: higher.

TableYounger mentypical level: patients 27, healthy 17Younger womentypical level: patients 13, healthy 11Older mentypical level: patients 29, healthy 21Older womentypical level: patients 18.8, healthy 17Over healthy limitpatients 3.4–8.6 times as likelyno changeThe summarypatients’ ALT “lower” in all four groups
TableYounger mentypical level:patients 27, healthy 17Younger womentypical level:patients 13, healthy 11Older mentypical level:patients 29, healthy 21Older womentypical level:patients 18.8, healthy 17Over healthy limitpatients 3.4–8.6 times as likelyno changeThe summarypatients’ ALT “lower”in all four groups

ALT in patients vs healthy people, lab units (healthy limit: 40 men, 35 women)

The paper says

The study compared 438 COVID-19 patients with no other illness to 369 healthy people, each split into four groups: younger men, younger women, older men, older women. Its summary says patients in all four had “lower” ALT, which damaged liver cells leak into the blood.

Its own data show

In the paper’s own results table, the typical patient had more ALT than the typical healthy person in every group, and patients were 3.4 to 8.6 times as likely to be over the healthy limit. For typical levels, the paper’s tests make chance unlikely in younger people but possible in the smaller older groups.

ALT (alanine aminotransferase) is a protein that leaks from damaged liver cells into the blood, so more ALT is a sign of liver damage. The paper’s results text agrees with its table, and its discussion says the infection “damages liver function”. Only one sentence of the summary, the part most people read, points the opposite way.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Sex- and age-specific clinical and immunological features of coronavirus disease 2019 · PLoS Pathog (2021) · doi:10.1371/journal.ppat.1009420